Hydrocortisone in Severe Community-Acquired Pneumonia.
暂无分享,去创建一个
B. Souweine | B. Giraudeau | H. Faure | E. L’her | J. Mira | J. Reignier | C. Guitton | F. Meziani | J. Quenot | N. Heming | A. Gacouin | J. Badie | N. Terzi | S. Gibot | S. Hraiech | J. Ricard | J. Frat | G. Plantefeve | A. Le Gouge | P. Dequin | S. Vimeux | G. Colin | G. Voiriot | Jean-Etienne Herbrecht | G. Louis | H. Bourgoin | M. Leclerc | T. Kamel | C. Lengellé | A. Joret | C. Giacardi | Mercedes Jourdain | B. François | Carine Coffre | Caroline Caille-Fénérol | Camille Bouisse | N. Barbarot | C. Quentin | M. Jourdain
[1] Grant D. Huang,et al. Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia , 2022, Intensive Care Medicine.
[2] W. Bos,et al. Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial , 2021, European Respiratory Journal.
[3] S. Peters,et al. Sex differences in response to adjunctive corticosteroid treatment for patients with septic shock , 2021, Intensive Care Medicine.
[4] D. Annane,et al. Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial. , 2020, JAMA.
[5] Sarah Zohar,et al. Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience , 2020, Statistics in biopharmaceutical research.
[6] R. Cavallazzi,et al. The Burden of Community-Acquired Pneumonia Requiring Admission to an Intensive Care Unit in the United States. , 2020, Chest.
[7] F. Blasi,et al. Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia , 2018, European Respiratory Journal.
[8] W. Boersma,et al. Corticosteroids in Patients Hospitalized With Community-Acquired Pneumonia: Systematic Review and Individual Patient Data Metaanalysis , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] William A. Mattingly,et al. Adults Hospitalized With Pneumonia in the United States: Incidence, Epidemiology, and Mortality , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] A. Anzueto,et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. , 2015, JAMA.
[11] Q. Xiu,et al. Corticosteroids in the Treatment of Community-Acquired Pneumonia in Adults: A Meta-Analysis , 2012, PloS one.
[12] J. Dorca,et al. Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial , 2011, Critical care.
[13] T. Welte,et al. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality , 2009, Thorax.
[14] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[15] C. Sherbourne,et al. The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .
[16] P. Armitage,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.